Product Program year 2025 Source: CMS Open Payments

ENROUTE Transcarotid Stent

Device ENROUTE Transcarotid Stent - PI

PDI 00811311021291

Open in the dashboard

General payments

$169,910

1,345 payments

Research payments

$0

0 payments

Through program year 2025, $169,910 in general payments and $0 in research payments were reported against ENROUTE Transcarotid Stent (ENROUTE Transcarotid Stent - PI).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $169,910 1,345

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $169,910 1,345 payments
Top recipients General payments · program year 2025
  1. Charlie Cheng Vascular Surgery · Galveston, TX $37,043 22% · 59 payments
  2. Tsz Lau Neurological Surgery · Sugar Land, TX $22,694 13% · 51 payments
  3. Scott Simon Neurological Surgery · Hershey, PA $16,997 10% · 27 payments
  4. Radmehr Torabi Neurological Surgery · Providence, RI $13,425 8% · 7 payments
  5. Gregg Landis Vascular Surgery · New Hyde Park, NY $12,098 7% · 32 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $95,557 57% · 317 practitioners
  2. Neurological Surgery $53,383 32% · 7 practitioners
  3. Surgery $3,187 2% · 45 practitioners
  4. Physician Assistant $2,550 2% · 56 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,483 1% · 60 practitioners

The top 5 of 47 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $62,721 37% · 59 recipients
  2. Pennsylvania $17,784 10% · 25 recipients
  3. Rhode Island $13,668 8% · 3 recipients
  4. New York $13,451 8% · 28 recipients
  5. Missouri $11,699 7% · 39 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,345 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record